tweenvest

Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHSE: 688806)

Health Care · Biotechnology · CN

CN¥21.97

-5.02% today · -51.3% 1Y

Public summary
A free snapshot of Zhuhai Trinomab Pharmaceutical Co., Ltd., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHSE: 688806) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.52B.

Over the last twelve months the share price has lost 51.3%, trading between 19.84 and 52.52.

Tweenvest scores Zhuhai Trinomab Pharmaceutical Co., Ltd. across four factors: quality 30/100, value 76/100. Its strongest factor is value.

688806 price history

Jul 24, 2026 · 26.60Weekly closes 20.11 – 30.67Nov 13, 2026 · 21.97

Key figures

Market cap
$1.52B
Revenue (TTM)
$26.14M
P/E
-18.12
EPS
-1.56
Dividend yield
—
Beta (5Y)
—
52-week high
CN¥52.52
52-week low
CN¥19.84
Avg volume (3M)
—
Shares outstanding
460.55M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Mesoblast LimitedASX: MSB$1.53BAU$1.76-1.95%
Vitrolife AB (publ)OM: VITR$1.53BSkr117.40-0.25%
Kailera Therapeutics, Inc.NasdaqGS: KLRA$1.53B$11.79-3.36%
TLC BioSciences Corp.TPEX: 7924$1.52BNT$375.00-2.47%
Voronoi, Inc.KOSDAQ: A310210$1.51B₩111,000.00+1.19%
CanSino Biologics Inc.SEHK: 6185$1.50BHK$23.34-1.85%
AlvotechNasdaqGM: ALVO$1.50B$4.19-10.28%
Korsana Biosciences, Inc.NasdaqCM: KRSA$1.49B$32.68+3.25%

Browse every Biotechnology company →